1,490
Views
2
CrossRef citations to date
0
Altmetric
Pulmonary Medicine

The effects of different inhalation therapies on less symptomatic chronic obstructive pulmonary disease patients in a Chinese population: a real-world study

, , , ORCID Icon, , ORCID Icon, , , , , , , & show all
Pages 1317-1324 | Received 02 Nov 2022, Accepted 13 Mar 2023, Published online: 29 Mar 2023

Figures & data

Figure 1. Flow chart. COPD: Chronic Obstructive Pulmonary Disease; ICS: Inhaled Corticosteroid; LAMA: Long-Acting Muscarinic Antagonist; LABA: Long-Acting β2-Agonist.

Figure 1. Flow chart. COPD: Chronic Obstructive Pulmonary Disease; ICS: Inhaled Corticosteroid; LAMA: Long-Acting Muscarinic Antagonist; LABA: Long-Acting β2-Agonist.

Table 1. Baseline characteristics of the total less symptomatic COPD patients.

Table 2. Description of inhalation therapy.

Table 3. The clinical characteristics of different inhalation therapies on less symptomatic COPD patients.

Table 4. Exacerbation and mortality during one year of follow-up of different inhalation therapies on less symptomatic COPD patients.

Table 5. Exacerbation and mortality during one year of follow-up of different inhalation therapies on Groups A and C patients.

Supplemental material

Supplemental Material

Download MS Word (39.6 KB)

Data availability statement

All data of this study are available from the corresponding author Ping Chen for reasonable request.